News
DGAP-News: MicroVision Releases Videos of Track Testing for Ground-Truth Data
Chemed Reports First-Quarter 2022 Results
Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest
DGAP-Adhoc: 2021 financial figures of Vita 34 AG expected to be significantly below market expectations due to several special effects on earnings development
Agilent to Announce Second-Quarter Fiscal Year 2022 Financial Results May 24
Agilent Technologies Inc. (NYSE: A) today announced that it will release financial results for the second quarter of fiscal year 2022 after the stock market closes on Tuesday, May 24. The company
PAVmed to Hold a Business Update Conference Call on May 12, 2022
PAVmed Inc. (Nasdaq: PAVM, PAVMZ), a highly differentiated, multi-product, commercial-stage medical device company today announced that the Company will host a business update conference call on
DexCom Showcases Expanded CGM Portfolio at International ATTD Conference, Offering More Choice to People With Diabetes
DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, will showcase for the first time its new global portfolio of real-time continuous
Lucid Diagnostics to Hold a Business Update Conference Call on May 11, 2022
Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”) a commercial-stage, cancer prevention medical diagnostics company, a majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ), today announced
Premier, Inc. Declares Quarterly Cash Dividend
Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that its Board of Directors declared a quarterly cash dividend of $0.20 per share of Class
Annual General Meeting - Shareholders approve all proposals of the Board of Directors
Simulations Plus Enters New Collaboration to Advance DDDPlus™ Software
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries, today announced a new
DGAP-News: MicroVision Inc.: MicroVision to Announce First Quarter 2022 Results on April 27, 2022
STAAR Surgical to Report First Quarter Results on May 4, 2022
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release
Simulations Plus to Present at the Berenberg Discover AI Seminar
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that management will be
Agilent Joins the National Institute for Innovation in Manufacturing to Advance Biomanufacturing
Agilent Technologies Inc. (NYSE: A) announced that it has joined the National Institute for Innovation in Manufacturing to Advance Biomanufacturing (NIIMBL). Membership in NIIMBL demonstrates
Humana’s Impact Report Focuses on Building Trust and Transparency in Journey to Health Equity
Humana Inc. (NYSE: HUM), one of the nation’s leading health and well-being companies, released its 2021 Impact Report, which highlights the company’s continued commitment to its Environment
Acadia Healthcare Announces Date for First Quarter 2022 Earnings Release
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it will release its first quarter 2022 results on Tuesday, May 3, 2022, after the close of the market. Acadia will conduct a
DGAP-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures for the first quarter of 2022 - Increasing difficulties in the supply of electronic components make the lower end of the full-year guidance likely
DGAP-Adhoc: Drägerwerk AG & Co. KGaA: Vorläufige Zahlen für das 1. Quartal 2022 - Zunehmende Schwierigkeiten bei der Lieferung elektronischer Bauteile machen das untere Ende der Jahresprognose wahrscheinlich
Humana Expands National Commitment to Affordable Housing With Additional $25 Million Investment
As part of its national commitment to improve housing stability for vulnerable members and communities, Humana Inc. (NYSE: HUM) today announced an additional $25 million investment in three
Quidel to Hold Fiscal First Quarter 2022 Financial Results Conference Call on May 4th, 2022
Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, will report fiscal first quarter 2022
Humana Throws the First Pitch Event to Connect Minority-Owned Businesses to Top Humana Suppliers
The Supplier Diversity Team of Humana Inc. (NYSE: HUM) hosted the First Pitch, a virtual forum where participants from the Humana Mentor Protégé Program had the opportunity to pitch their business
NanoString Highlights Spatial Biology Research at the 2022 American Association of Cancer Research (AACR) Conference
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the highlights of over 125 studies enabled by
LivaNova Initiates Targeted Commercial Launch of the Essenz Patient Monitor for Cardiopulmonary Bypass Procedures
LivaNova PLC (NASDAQ: LIVN), a market-leading medical technology and innovation company, today announced receipt of regulatory approvals and the start of a targeted commercial launch for the
Agilent Highlights Genomics and Cell Analysis Solutions for Cancer Research at AACR 2022
Agilent Technologies Inc. (NYSE: A) today announced cancer research innovations in cell analysis and genomics that will be on show at the American Association for Cancer Research Annual Meeting
Quidel Announces Preliminary Revenue for First Quarter 2022
Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it expects